ORGO profile · all as-reported value updates
Organogenesis Holdings Inc. (ORGO) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2017 | 5,000,008 | -15,317,000 | -20,317,008 | -132.64% | revised comparative figure | 0001558370-18-002068 0001193125-21-082849 | 4 filed observations examined for this concept and period. |
| Stockholders' equity | 2016 | 5,000,001 | -15,979,000 | -20,979,001 | -131.29% | revised comparative figure | 0001047469-17-002096 0001193125-20-067198 | 4 filed observations examined for this concept and period. |
| Net income | 2016 | -208,698 | -16,987,000 | -16,778,302 | -98.77% | revised comparative figure | 0001047469-17-002096 0001193125-19-078332 | 3 filed observations examined for this concept and period. |
| Operating income | 2016 | -208,698 | -8,775,000 | -8,566,302 | -97.62% | revised comparative figure | 0001558370-18-002068 0001193125-19-078332 | 2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |
| Liabilities | 2017 | 14,778,722 | 157,277,000 | 142,498,278 | +90.60% | revised comparative figure | 0001558370-18-002068 0001193125-19-078332 | 2 filed observations examined for this concept and period. |
| Operating cash flow | 2016 | -562,233 | -4,871,000 | -4,308,767 | -88.46% | revised comparative figure | 0001558370-18-002068 0001193125-19-078332 | 2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |
| Operating cash flow | 2017 | -586,604 | -3,493,000 | -2,906,396 | -83.21% | revised comparative figure | 0001558370-18-002068 0001193125-20-067198 | 3 filed observations examined for this concept and period. |
| Net income | 2017 | -2,093,913 | -8,388,000 | -6,294,087 | -75.04% | revised comparative figure | 0001558370-18-002068 0001193125-20-067198 | 3 filed observations examined for this concept and period. |
| Assets | 2017 | 312,792,360 | 148,722,000 | -164,070,360 | -52.45% | revised comparative figure | 0001558370-18-002068 0001193125-19-078332 | 2 filed observations examined for this concept and period. |
| Operating cash flow | 2020 | 6,801,000 | 5,466,000 | -1,335,000 | -19.63% | revised comparative figure | 0001193125-21-082849 0000950170-23-005585 | 3 filed observations examined for this concept and period. |
| Capital expenditures | 2020 | 21,145,000 | 17,678,000 | -3,467,000 | -16.40% | revised comparative figure | 0001193125-21-082849 0000950170-23-005585 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2018 | 47,041,000 | 39,939,000 | -7,102,000 | -15.10% | revised comparative figure | 0001193125-19-078332 0001193125-22-061686 | 4 filed observations examined for this concept and period. |
| Stockholders' equity | 2019 | 55,583,000 | 52,022,000 | -3,561,000 | -6.41% | revised comparative figure | 0001193125-20-067198 0000950170-23-005585 | 4 filed observations examined for this concept and period. |
| Net income | 2019 | -40,454,000 | -38,709,000 | 1,745,000 | +4.31% | revised comparative figure | 0001193125-20-067198 0001193125-22-061686 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2020 | 146,084,000 | 141,808,000 | -4,276,000 | -2.93% | revised comparative figure | 0001193125-21-082849 0000950170-24-023150 | 4 filed observations examined for this concept and period. |
| Assets | 2020 | 294,494,000 | 290,218,000 | -4,276,000 | -1.45% | revised comparative figure | 0001193125-21-082849 0001193125-22-061686 | 2 filed observations examined for this concept and period. |